Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Penumbra stock price, quote, forecast and news

PEN
US70975L1070
A14Y65

Price

191.55
Today +/-
-0.07
Today %
-0.04 %
P

Penumbra stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Penumbra stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Penumbra stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Penumbra stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Penumbra's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Penumbra Stock Price History

DatePenumbra Price
9/27/2024191.55 undefined
9/26/2024191.63 undefined
9/25/2024186.89 undefined
9/24/2024191.40 undefined
9/23/2024194.90 undefined
9/20/2024195.00 undefined
9/19/2024200.82 undefined
9/18/2024195.58 undefined
9/17/2024187.06 undefined
9/16/2024187.65 undefined
9/13/2024186.94 undefined
9/12/2024200.01 undefined
9/11/2024202.31 undefined
9/10/2024204.12 undefined
9/9/2024195.08 undefined
9/6/2024203.73 undefined
9/5/2024204.04 undefined
9/4/2024202.55 undefined
9/3/2024204.97 undefined

Penumbra Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Penumbra, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Penumbra from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Penumbra’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Penumbra. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Penumbra’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Penumbra’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Penumbra’s growth potential.

Penumbra Revenue, EBIT and net profit per share

DatePenumbra RevenuePenumbra EBITPenumbra Net Income
2028e2.22 B undefined409.05 M undefined318.53 M undefined
2027e1.9 B undefined334.46 M undefined253.02 M undefined
2026e1.58 B undefined262.84 M undefined191.88 M undefined
2025e1.38 B undefined193.93 M undefined141.59 M undefined
2024e1.2 B undefined142.02 M undefined102.72 M undefined
20231.06 B undefined91.77 M undefined90.95 M undefined
2022847.1 M undefined6.1 M undefined-2 M undefined
2021747.6 M undefined18.3 M undefined5.3 M undefined
2020560.4 M undefined-18.6 M undefined-15.7 M undefined
2019547.4 M undefined47.5 M undefined48.5 M undefined
2018444.9 M undefined29.9 M undefined6.6 M undefined
2017333.8 M undefined1.2 M undefined4.7 M undefined
2016263.3 M undefined-1.4 M undefined14.8 M undefined
2015186.1 M undefined4.2 M undefined1.1 M undefined
2014125.5 M undefined3 M undefined-800,000 undefined
201388.8 M undefined-1.1 M undefined900,000 undefined
201273.1 M undefined3.4 M undefined400,000 undefined

Penumbra Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e
0.070.090.130.190.260.330.440.550.560.750.851.061.21.381.581.92.22
-20.5542.0548.8041.4026.6233.3323.202.3833.3913.3924.9113.4214.6714.8320.0017.14
67.1264.7765.6066.6764.6465.1765.7768.0160.3663.5963.1664.46-----
49578212417021729237233847553568200000
3-134-112947-1818691142193262334409
4.11-1.142.402.15-0.380.306.538.59-3.212.410.718.6011.8314.0316.5817.6218.42
0001144648-155-290102141191253318
----1,300.00-71.4350.00700.00-131.25-133.33-140.00-4,600.0013.3338.2435.4632.4625.69
29.829.829.814.233.535.336.136.335.837.937.839.2200000
-----------------
Details

Keystats

ⓘ

Revenue and Growth

The Penumbra Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Penumbra is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (k)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (B)
20132014201520162017201820192020202120222023
                     
13.751.5148.8128.8214.6200.9189.4264.8254.9188289.19
13.118.929.443.35881.9105.9114.6133.9203.4201.77
0.11.70.74.60000000
27.133.556.87394.9115.7153219.5263.5334388.02
8.49.78.714.214.712.214.918.729.230.336.42
62.4115.3244.4263.9382.2410.7463.2617.6681.5755.7915.4
25.2921.530.935.4135.5127.4227.1291292.54
00003.9000000
00000000000
000023.827.225.410.690.681.271.06
00008.27.87.78.4166.4166166.27
6.90.910.52327.733.834.358.878.777111.04
8.96.119.544.594.5104.2202.9205.2562.8615.2640.9
0.070.120.260.310.480.510.670.821.241.371.56
                     
56.2111.5000000000.04
0.010.010.250.270.40.420.430.60.910.961.05
-15-19.8-17.5-2.729.157.540.645.943.9134.86
0.7-1-2-4.61.8-1.4-2.61.9-2-4.6-2.59
00-200-100-200-500200600-600-3,500-558
0.050.10.230.270.40.420.490.640.9511.18
1.32.32.64.16.88.215.114.113.426.727.16
13.416.623.929.93951.665.284.6108.1107.2114.77
1.11.91.61.85.86.36.65.909.26.99
00000000000
0000004.21.31.71.92.23
15.820.828.135.851.666.191.1105.9123.2145151.14
60000026.727.126.524.923.68
00003.34.244.8000
1.21.53.25.921.422.458.547.4140.6202.2202.54
7.21.53.25.924.726.689.279.3167.1227.1226.22
2322.331.341.776.392.7180.3185.2290.3372.1377.36
0.070.120.260.310.480.520.670.831.241.371.56
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Penumbra provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Penumbra's financial health and stability.

Assets

Penumbra's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Penumbra must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Penumbra after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Penumbra's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (k)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20132014201520162017201820192020202120222023
422144247-192-290
001236812162427
00-3,000-12,000-4,000-6,0001,000-18,000-14,0001,000-19,000
-5-12-30-36-13-30-56-51-66-121-79
-1416333974486813779127
00000000000
03120001126
-3-6-20-12122826-339-5597
0-3-5-13-15-9-22-24-21-19-15
-1-37-850-770-12-104-2154-16
0-33-8014-6299-790740
00000000000
2-600-10-2-3-1-1-1
04812591171213151182120
2421227104-9-813401116
---2.00-2.00-11.00-21.00-19.00-12.00-16.00-8.00-2.00
00000000000
-3016-637174-3-101097
-4.2-10.28-26.16-26.45-2.3419.214.54-58-11.68-74.9682.12
00000000000

Penumbra stock margins

The Penumbra margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Penumbra. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Penumbra.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Penumbra's sales revenue. A higher gross margin percentage indicates that the Penumbra retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Penumbra's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Penumbra's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Penumbra's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Penumbra. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Penumbra's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Penumbra Margin History

Penumbra Gross marginPenumbra Profit marginPenumbra EBIT marginPenumbra Profit margin
2028e64.49 %18.42 %14.34 %
2027e64.49 %17.64 %13.35 %
2026e64.49 %16.62 %12.14 %
2025e64.49 %14.08 %10.28 %
2024e64.49 %11.84 %8.56 %
202364.49 %8.67 %8.59 %
202263.18 %0.72 %-0.24 %
202163.59 %2.45 %0.71 %
202060.35 %-3.32 %-2.8 %
201967.96 %8.68 %8.86 %
201865.75 %6.72 %1.48 %
201765.04 %0.36 %1.41 %
201664.87 %-0.53 %5.62 %
201566.68 %2.26 %0.59 %
201465.98 %2.39 %-0.64 %
201365.2 %-1.24 %1.01 %
201267.03 %4.65 %0.55 %

Penumbra Stock Sales Revenue, EBIT, Earnings per Share

The Penumbra earnings per share therefore indicates how much revenue Penumbra has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Penumbra earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Penumbra's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Penumbra’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Penumbra's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Penumbra Revenue, EBIT and net profit per share

DatePenumbra Sales per SharePenumbra EBIT per sharePenumbra Earnings per Share
2028e57.18 undefined0 undefined8.2 undefined
2027e48.82 undefined0 undefined6.51 undefined
2026e40.71 undefined0 undefined4.94 undefined
2025e35.45 undefined0 undefined3.65 undefined
2024e30.9 undefined0 undefined2.64 undefined
202326.99 undefined2.34 undefined2.32 undefined
202222.41 undefined0.16 undefined-0.05 undefined
202119.73 undefined0.48 undefined0.14 undefined
202015.65 undefined-0.52 undefined-0.44 undefined
201915.08 undefined1.31 undefined1.34 undefined
201812.32 undefined0.83 undefined0.18 undefined
20179.46 undefined0.03 undefined0.13 undefined
20167.86 undefined-0.04 undefined0.44 undefined
201513.11 undefined0.3 undefined0.08 undefined
20144.21 undefined0.1 undefined-0.03 undefined
20132.98 undefined-0.04 undefined0.03 undefined
20122.45 undefined0.11 undefined0.01 undefined

Penumbra business model

Penumbra Inc is an American company specializing in medical technology. It was founded in 2004 and is headquartered in Alameda, California. The company has branches and subsidiaries worldwide. It offers various products for the treatment of strokes, aneurysms, vascular injuries, and other medical conditions. The history of Penumbra Inc began with the founder and CEO Adam Elsesser's vision to develop innovative technologies to help patients with challenging medical conditions. The company started with just one product, the Penumbra 3D Coiling Technology, which is used for the treatment of brain aneurysms. Penumbra Inc's business model is based on the development and marketing of innovative medical devices and technologies to assist surgeons and specialists in treating their patients better. The company conducts intensive research and development to create new products that meet market demand. Penumbra Inc is divided into different divisions to offer a comprehensive range of medical tools and devices to its customers. The main divisions of the company are Neuro, Vascular, and Oncology. Under the Neuro division, Penumbra Inc offers a wide range of devices and technologies for the treatment of strokes and trauma. This includes the Penumbra Coil 400, used for treating intracranial aneurysms, and the Penumbra Jet 7 Reperfusion Catheter, an innovative technology for restoring blood flow in stroke patients' brains. The Vascular division of Penumbra Inc provides devices for the treatment of vascular diseases, such as endovascular repairs of aortic aneurysms. This division utilizes the innovative Penumbra SMART Coil technology, which provides improved handling and safety. The Oncology division of Penumbra Inc focuses on developing technologies to enhance healthcare for cancer patients. This includes innovative drug delivery devices, such as the Penumbra System used in brachytherapy. Penumbra Inc is a leading provider of medical devices and technologies used in the treatment of complex medical conditions. Over the past decade, the company has established its reputation in the industry. Continuous investment in research and development and a focus on patient and medical professionals' needs have solidified Penumbra Inc's success in the international market. Penumbra is one of the most popular companies on Eulerpool.com.

Penumbra SWOT Analysis

Strengths

Penumbra Inc has several strengths that contribute to its success in the market. These include:

  • Strong brand recognition and reputation
  • High-quality and innovative products
  • Robust research and development capabilities
  • Global presence and diversified customer base
  • Efficient supply chain management

Weaknesses

Despite its strengths, Penumbra Inc also faces certain weaknesses that may hinder its growth prospects. These include:

  • Dependence on a few key customers
  • Relatively higher production costs compared to some competitors
  • Limited product portfolio in certain healthcare segments
  • Less established distribution networks in emerging markets

Opportunities

Penumbra Inc can leverage various opportunities to expand its market share and increase profitability. These opportunities include:

  • Growing demand for minimally invasive medical devices
  • Advancements in healthcare technology
  • Expanding into emerging markets with untapped potential
  • Strategic partnerships and collaborations
  • New product development and diversification

Threats

Penumbra Inc faces various threats that could impact its growth and profitability. These threats include:

  • Intense competition in the medical devices industry
  • Changing regulatory landscape
  • Economic downturns affecting healthcare spending
  • Potential disruptions in the supply chain
  • Rapid technological advancements by competitors

Penumbra Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Penumbra Revenue by Segment

Segmente202320222021202020192018201720162015
Neuro-347.74 M USD338.71 M USD292.63 M USD331.69 M USD294.33 M USD232.45 M USD185.53 M USD141.41 M USD
Vascular-499.39 M USD408.88 M USD267.78 M USD215.72 M USD150.61 M USD---
Thrombectomy677.34 M USD--------
Embolization and Other381.18 M USD--------
Peripheral Vascular------101.32 M USD77.78 M USD44.69 M USD

Penumbra Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Penumbra Revenue by Segment

DateInternationalJapanOther InternationalUnited States
2023301.37 M USD--757.15 M USD
2022255.42 M USD--591.72 M USD
2021--219.8 M USD527.79 M USD
2020--160.14 M USD400.27 M USD
2019-42.52 M USD149.66 M USD355.22 M USD
2018-41.81 M USD112.42 M USD290.72 M USD
2017-33.79 M USD80.8 M USD219.17 M USD
2016-30.28 M USD56.93 M USD176.1 M USD
2015-19.02 M USD39.77 M USD127.31 M USD

Penumbra Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Penumbra historical P/E ratio, EBIT, and P/S ratio.

Penumbra shares outstanding

The number of shares was Penumbra in 2023 — This indicates how many shares 39.217 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Penumbra earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Penumbra's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Penumbra’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Penumbra's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Penumbra.

Penumbra latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20240.56 0.64  (13.6 %)2024 Q2
3/31/20240.38 0.41  (7.3 %)2024 Q1
12/31/20230.71 0.76  (7.56 %)2023 Q4
9/30/20230.46 0.67  (45.87 %)2023 Q3
6/30/20230.28 0.43  (52.75 %)2023 Q2
3/31/20230.11 0.23  (109.09 %)2023 Q1
12/31/20220.15 0.16  (8.77 %)2022 Q4
9/30/20220.01 0.01  (19.05 %)2022 Q3
6/30/2022-0.03 0.01  (131.15 %)2022 Q2
3/31/20220.06 -0.01  (-117.73 %)2022 Q1
1
2
3
4

Eulerpool ESG Scorecard© for the Penumbra stock

Eulerpool World ESG Rating (EESG©)

58/ 100

🌱 Environment

49

👫 Social

76

🏛️ Governance

48

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
✅
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees50
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept✅
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Penumbra list of shareholders

%
Name
Stocks
Change
Date
9.39850 % The Vanguard Group, Inc.3,650,37857,77712/31/2023
8.79589 % BlackRock Institutional Trust Company, N.A.3,416,32425,39012/31/2023
7.88369 % T. Rowe Price Associates, Inc.3,062,0271,135,50312/31/2023
6.89441 % Capital Research Global Investors2,677,78927912/31/2023
2.83498 % State Street Global Advisors (US)1,101,10741,05312/31/2023
2.47833 % Elsesser (Adam)962,5825,0003/6/2024
2.06186 % ClearBridge Investments, LLC800,827-104,39512/31/2023
13.10181 % Fidelity Management & Research Company LLC5,088,744721,93612/31/2023
1.91364 % William Blair Investment Management, LLC743,25986,29512/31/2023
1.80409 % Fidelity Institutional Asset Management700,71050,53412/31/2023
1
2
3
4
5
...
10

Penumbra Executives and Management Board

Ms. Johanna Roberts51
Penumbra Executive Vice President, General Counsel, Secretary
Compensation 2.65 M
Ms. Maggie Yuen51
Penumbra Chief Financial Officer
Compensation 1.66 M
Mr. Lambert Shiu43
Penumbra Chief Accounting Officer
Compensation 1.04 M
Mr. Adam Elsesser61
Penumbra Chairman of the Board, President, Chief Executive Officer (since 2004)
Compensation 601,620
Ms. Bridget O'rourke55
Penumbra Independent Director
Compensation 229,417
1
2
3

Most common questions regarding Penumbra

What values and corporate philosophy does Penumbra represent?

Penumbra Inc represents a set of core values and a corporate philosophy centered around innovation, patient care, and improving healthcare outcomes. With a focus on developing and delivering groundbreaking medical technologies, Penumbra is committed to pushing the boundaries of medical advancements to enhance patient treatment and improve quality of life. The company prioritizes collaboration with healthcare professionals, continuously seeks to understand unmet clinical needs, and aims to provide effective solutions through its cutting-edge products and therapies. Penumbra's dedication to excellence, integrity, and customer satisfaction drives its mission to transform the way healthcare is practiced globally.

In which countries and regions is Penumbra primarily present?

Penumbra Inc is primarily present in multiple countries and regions across the globe. The company's presence extends to various regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East. With its headquarters in the United States, Penumbra Inc has established a strong presence in countries like Germany, France, China, Japan, Brazil, and the United Arab Emirates. By expanding their reach in different geographic regions, Penumbra Inc has successfully positioned themselves as a global player in the medical technology industry.

What significant milestones has the company Penumbra achieved?

Penumbra Inc, a renowned medical device company, has achieved several significant milestones. One notable accomplishment was the development and success of their flagship product, the Penumbra System, for the treatment of ischemic stroke. This groundbreaking innovation has revolutionized stroke care by providing an effective solution to remove blood clots from cerebral vessels. Additionally, Penumbra Inc has achieved remarkable growth in expanding its product portfolio by introducing advanced neurovascular, peripheral vascular, and neurosurgical devices. The company's commitment to innovation, coupled with its strong clinical outcomes, has positioned Penumbra Inc as a leader in the field, benefiting patients worldwide.

What is the history and background of the company Penumbra?

Penumbra Inc is a leading global healthcare company that specializes in innovative medical devices. Founded in 2004, Penumbra has consistently demonstrated its commitment to improving patient outcomes through ground-breaking technologies. Headquartered in Alameda, California, the company is renowned for its advanced products in neurovascular, neurosurgical, and peripheral vascular markets. With a strong emphasis on research and development, Penumbra has achieved significant milestones and gained recognition for its cutting-edge solutions. The company's dedication to improving patient care and its continuous pursuit of breakthrough technologies have solidified its position as a trusted leader in the medical device industry.

Who are the main competitors of Penumbra in the market?

The main competitors of Penumbra Inc in the market include Medtronic, Stryker Corporation, Johnson & Johnson, and Boston Scientific Corporation.

In which industries is Penumbra primarily active?

Penumbra Inc is primarily active in the healthcare industry.

What is the business model of Penumbra?

Penumbra Inc operates under a business model that focuses on developing innovative medical devices and technologies. The company primarily specializes in designing, manufacturing, and marketing medical catheters and related products. Penumbra Inc aims to improve patient outcomes by providing medical professionals with advanced tools for the diagnosis and treatment of complex medical conditions, particularly in the fields of neurovascular and peripheral vascular diseases. With a commitment to research and development, Penumbra Inc aims to continually introduce cutting-edge medical solutions that address unmet clinical needs, ultimately improving the quality of life for patients around the world.

What is the P/E ratio of Penumbra 2024?

The Penumbra P/E ratio is 73.13.

What is the P/S ratio of Penumbra 2024?

The Penumbra P/S ratio is 6.26.

What is the AlleAktien quality score of Penumbra?

The AlleAktien quality score for Penumbra is 4/10.

What is the revenue of Penumbra 2024?

The expected Penumbra revenue is 1.2 B USD.

How high is the profit of Penumbra 2024?

The expected Penumbra profit is 102.72 M USD.

What is the business model of Penumbra

Penumbra Inc is a publicly traded company based in California, USA. The company operates in the medical technology and healthcare management sectors. Penumbra Inc was established in 2004 and has since continued to evolve. The company's product range and services encompass a wide spectrum and are used globally. The business model of Penumbra Inc consists of various divisions. The company's main activity lies in the manufacture of medical devices and instruments. Penumbra Inc specializes in the development of devices for neurointervention. These devices are used in the treatment of strokes or severe head injuries. The goal is to optimize patient care and increase chances of recovery. The product range of Penumbra Inc includes catheters, stents, coil systems, and software solutions for neurointervention, among others. These products are used worldwide and have established themselves in medical care. The devices and instruments of Penumbra Inc are known for their high quality and performance. Another division of Penumbra Inc is healthcare management. Under the umbrella brand "Penumbra System of Care," the company provides services for healthcare management. Analysis programs and training are offered to support hospitals and medical facilities in increasing their efficiency and optimizing patient care. Penumbra Inc also relies on innovative technologies and continually invests in research and development. The aim is to continuously improve medical care. The company works closely with experts and clinics to constantly optimize its products and services. In summary, the business model of Penumbra Inc is very diverse. Through its various divisions, the company can address a broad customer portfolio and flexibly respond to developments in the healthcare sector. The products and services of Penumbra Inc set standards in neurointervention and contribute to the improvement of medical care. Through continuous investment in research and development, Penumbra Inc is an innovation leader in the field of medical technology.

What is the Penumbra dividend?

Penumbra pays a dividend of 0 USD distributed over payouts per year.

How often does Penumbra pay dividends?

The dividend cannot currently be calculated for Penumbra or the company does not pay out a dividend.

What is the Penumbra ISIN?

The ISIN of Penumbra is US70975L1070.

What is the Penumbra WKN?

The WKN of Penumbra is A14Y65.

What is the Penumbra ticker?

The ticker of Penumbra is PEN.

How much dividend does Penumbra pay?

Over the past 12 months, Penumbra paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Penumbra is expected to pay a dividend of 0 USD.

What is the dividend yield of Penumbra?

The current dividend yield of Penumbra is .

When does Penumbra pay dividends?

Penumbra pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Penumbra?

Penumbra paid dividends every year for the past 0 years.

What is the dividend of Penumbra?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Penumbra located?

Penumbra is assigned to the 'Health' sector.

Wann musste ich die Aktien von Penumbra kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Penumbra from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Penumbra pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Penumbra in the year 2023?

In the year 2023, Penumbra distributed 0 USD as dividends.

In which currency does Penumbra pay out the dividend?

The dividends of Penumbra are distributed in USD.

All fundamentals about Penumbra

Our stock analysis for Penumbra Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Penumbra Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.